ArticleJournal of cancer research and clinical oncology2025

Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin.

John S Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.